Back to Search
Start Over
Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?
- Source :
- Journal of Clinical Investigation. January 1, 2022, Vol. 132 Issue 1
- Publication Year :
- 2022
-
Abstract
- To the Editor: The article by Wang et al. (1) challenges the concept, proposed and developed by us, that endocannabinoids acting via hepatic cannabinoid receptor 1 (CB-1) contribute to nonalcoholic [...]
- Subjects :
- Health care industry
Subjects
Details
- Language :
- English
- ISSN :
- 00219738
- Volume :
- 132
- Issue :
- 1
- Database :
- Gale General OneFile
- Journal :
- Journal of Clinical Investigation
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.690103045